Characterization of DCTN1 genetic variability in neurodegeneration.
about
Phenotypic Heterogeneity of Monogenic Frontotemporal DementiaTubulin-binding cofactor B is a direct interaction partner of the dynactin subunit p150(Glued)DNAJC13 mutations in Parkinson diseaseMechanism and regulation of cytoplasmic dyneinProtein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?Prognostic transcriptional association networks: a new supervised approach based on regression trees.Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway.Frontotemporal dementia in a Brazilian kindred with the c9orf72 mutation.Phenotypic and molecular analyses of primary lateral sclerosis.Analysis of CYP27B1 in multiple sclerosisIdentification of FUS p.R377W in essential tremorRegulated protein aggregation: stress granules and neurodegeneration"Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.Microtubule defects & Neurodegeneration.Atypical Parkinsonian syndromes: a general neurologist's perspective.Genetics of FTLD: overview and what else we can expect from genetic studies.Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?DCTN1-related neurodegeneration: Perry syndrome and beyond.Mutation analysis of genes within the dynactin complex in a cohort of hereditary peripheral neuropathies.Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases.Dynactin Deficiency in the CNS of Humans with Sporadic ALS and Mice with Genetically Determined Motor Neuron DegenerationCombining Structure-Function and Single-Molecule Studies on Cytoplasmic Dynein.Establishing diagnostic criteria for Perry syndrome.Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes.Familial Amyotrophic Lateral Sclerosis.
P2860
Q26782984-D457EF25-5084-4CB1-AC21-A5B4F3BC3C8DQ28115739-EB0D9D7A-EA74-403C-9314-0A4AA357D346Q28658355-1E999D82-DC6B-4FBB-9B51-C15E8EC76324Q30676872-74B25A14-6466-4CED-90C7-8D3183F8F7A0Q33621868-9FA62A9F-42C9-40D8-994D-136CA8E42E01Q34480079-71946023-C9F6-4B66-B22B-4D26BAAF8F3AQ35014424-D02A3639-C12C-4B79-B758-B026A00BEB5EQ36763619-55D56894-60D0-4B10-97C9-46C6A0986BFCQ36766094-9615EC26-E0A0-4644-8AED-2DDA4B7A8402Q37388834-241C2D73-397E-40D8-B90D-3F29D3837AB2Q37388862-54704219-7AD2-4DBD-8676-4EB0284F44A6Q38060891-A49F8062-488B-4837-80FE-94911C4699BEQ38110488-E36AF8BA-8191-4D3E-9F75-4001924D81F1Q38190551-2C0B9939-E8E4-4238-BCC6-91E3724DC422Q38372272-616848E6-56EF-4D42-8E4D-C098B3B0887AQ38786774-57146A74-37D4-4C52-B345-E00185A11E6BQ39149919-5020B489-59AB-4432-BB36-7B804545A61CQ39381016-B02E16F0-D289-4E01-9FAF-45DF589A37EDQ40216659-3490C72A-3798-42E0-B452-CDF0746A76BBQ40955054-A22A1FE5-8F45-4BE1-9536-666F4FEE5795Q41883935-2F04B9D8-079F-47E9-A3C9-A0C68BEFD68DQ47111878-F90EBBB9-097C-4916-BFA0-57BB19886CB4Q47580903-023BC135-87BC-4B4B-82CA-C2141919B128Q47803051-CB45898A-D829-44B1-AF01-7360E2567753Q50488070-F73FAA59-0E86-4198-8E6F-8BAFAE0876FFQ54158931-6AC6772F-FB55-48CB-9E49-EF96105A12C9
P2860
Characterization of DCTN1 genetic variability in neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of DCTN1 genetic variability in neurodegeneration.
@en
Characterization of DCTN1 genetic variability in neurodegeneration.
@nl
type
label
Characterization of DCTN1 genetic variability in neurodegeneration.
@en
Characterization of DCTN1 genetic variability in neurodegeneration.
@nl
prefLabel
Characterization of DCTN1 genetic variability in neurodegeneration.
@en
Characterization of DCTN1 genetic variability in neurodegeneration.
@nl
P2093
P2860
P50
P1433
P1476
Characterization of DCTN1 genetic variability in neurodegeneration
@en
P2093
A I Soto-Ortolaza
A Krygowska-Wajs
B H Keeling
J C Dachsel
P2860
P304
P356
10.1212/WNL.0B013E3181A92C4C
P407
P50
P577
2009-06-01T00:00:00Z